18β-glycyrrhetinic acid (concur) induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 1923-1931

  Sharma, Gunjan ^a   Kar, Susanta ^a   Palit, Shreyasi ^a   Das, Pijush K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; CASPASE 9; CYTOCHROME C; GLYCYRRHETINIC ACID; PHOSPHATIDYLSERINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHRL1;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; DNA FRAGMENTATION; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 9; CELL LINE, TUMOR; ENZYME ACTIVATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLYCYRRHETINIC ACID; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

GLYCYRRHIZA;

EID: 84856170495     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22920     Document Type: Article

References (43)

1. Biswas SC, Shi Y, Sproul A, Greene LA. 2007. Pro-apoptotic Bim induction in response to nerve growth factor deprivation requires simultaneous activation of three different death signaling pathways. J Biol Chem 282: 29368-29374.
2. Curreli F, Friedman-Kien AE, Flore O. 2005. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J Clin Invest 115: 642-652.
3. Cuzick J. 2010. Tamoxifen and the factor V Leiden mutation. J Natl Cancer Inst 102: 918-919.
4. Delivani P, Martin SJ. 2006. Mitochondrial membrane remodeling in apoptosis: An inside story. Cell Death Differ 13: 2007-2010.
5. Dent SF, Gaspo R, Kissner M, Pritchard KI. 2011. Aromatase inhibitor therapy: Toxicities and management strategies in the treatment of postmenopausal women with hormone sensitive early breast cancer. Breast Cancer Res Treat 126: 295-310.
6. Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R. 2010. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28: 509-518.
7. Earnshaw WC, Martins LM, Kaufmann SH. 1999. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68: 383-424.
8. Egle A, Harris AW, Bouillet P, Cory S. 2004. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 101: 6164-6169.
9. Farina C, Pinza M, Pifferi G. 1998. Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids. Farmaco 53: 22-32.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
11. Gilley J, Coffer PJ, Ham J. 2003. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162: 613-622.
12. Hibasami H, Iwase H, Yoshioka K, Takahashi H. 2005. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60cells. Int J Mol Med 16: 233-236.
13. Hoever G, Baltina L, Michaelis M, Kondratenko R, Tolstikov GA, Doerr HW, Cinatl J Jr. 2005. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem 48: 1256-1259.
14. Hosaka T, Biggs WH 3rd, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC. 2004. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 101: 2975-2980.
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin 61: 134.
16. Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
17. Juan ME, Planas JM, Ruiz-Gutierrez V, Daniel H, Wenzel U. 2008. Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells. Br J Nutr 100: 36-43.
18. Krahenbuhl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R. 1994. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab 78: 581-585.
19. Krol J, Francis RE, Albergaria A, Sunters A, Polychronis A, Coombes RC, Lam EW. 2007. The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells. Mol Cancer Ther 12: 3169-3179.
20. Kumar S, Walia V, Ray M, Elble RC. 2007. p53 in breast cancer: Mutation and countermeasures. Front Biosci 12: 4168-4178.
21. Langer S, Singer CF, Hudelist G, Dampier B, Kaserer K, Vinatzer U, Pehamberger H, Zielinski C, Kubista E, Schreibner M. 2006. Jun and Fos family protein expression in human breast cancer: Correlation of protein expression and clinicopathological parameters. Eur J Gynaecol Oncol 27: 345-352.
22. Lee CS, Kim YJ, Lee MS, Han ES, Lee SJ. 2008. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity. Life Sci 83: 481-489.
23. Liu W, Bagaitkar J, Watabe K. 2007. Roles of AKT signal in breast cancer. Front Biosci 12: 4011-4019.
24. Lomonosova E, Chinnadurai G. 2008. BH3-only proteins in apoptosis and beyond: An overview. Oncogene 27: 2-19.
25. Love RR. 2002. Breast cancer prevention. Oncologist 7: 100-102.
26. Lumachi F, Luisetto G, Basso SM, Basso U, Brunello A, Camozzi V. 2011. Endocrine therapy of breast cancer. Curr Med Chem 18: 513-522.
27. Mandal M, Crusio KM, Meng F, Liu S, Kinsella M, Clark MR, Takeuchi O, Aifantis I. 2008. Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid. Proc Natl Acad Sci USA 105: 20840-20845.
28. Martin R, Carvalho-Tavares J, Ibeas E, Hernandez M, Ruiz-Gutierrez V, Nieto ML. 2007. Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation. Cancer Res 67: 3741-3751.
29. Nagata S. 1997. Apoptosis by death factor. Cell 88: 355-365.
30. Newman DJ, Cragg GM, Snader KM. 2003. Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037.
31. Obexer P, Geiger K, Ambros PF, Meister B, Ausserlechner MJ. 2007. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ 14: 534-547.
32. Polter A, Yang S, Zmijewska AA, van Groen T, Paik JH, Depinho RA, Peng SL, Jope RS, Li X. 2009. Forkhead box, class O transcription factors in brain: Regulation and behavioral manifestation. Biol Psychiatry 65: 150-159.
33. Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. 1999. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3: 287-296.
34. Rabi T, Shukla S, Gupta S. 2008. Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3cells. Mol Carcinog 47: 964-973.
35. Rossi T, Benassi L, Magnoni C, Ruberto AI, Coppi A, Baggio G. 2005. Effects of glycyrrhizin on UVB-irradiated melanoma cells. In Vivo 19: 319-322.
36. Rossi T, Castelli M, Zandomeneghi G, Ruberto A, Benassi L, Magnoni C, Santachiara S, Baggio G. 2003. Selectivity of action of glycyrrhizin derivatives on the growth of MCF-7 and HEP-2cells. Anticancer Res 23: 3813-3818.
37. Salvi M, Fiore C, Armanini D, Toninello A. 2003. Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria. Biochem Pharmacol 66: 2375-2379.
38. Sunters A, Fernandez de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC, Lam EW. 2003. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278: 49795-49805.
39. Tan TT, Degenhardt K, Nelson DA, Beaudoin B, Nieves-Neira W, Bouillet P, Villunger A, Adams JM, White E. 2005. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 7: 227-238.
40. Tsuda H, Okamoto H. 1986. Elimination of metabolic cooperation by glycyrrhetinic acid, an anti-tumor promoter, in cultured Chinese hamster cells. Carcinogenesis 7: 1805-1807.
41. Ukil A, Biswas A, Das T, Das PK. 2005. 18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B. J Immunol 175: 1161-1169.
42. Weng SC, Kashida Y, Kulp SK, Wang D, Brueggemeier RW, Shapiro CL, Chen CS. 2008. Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Mol Cancer Ther 7: 800-808.
43. Yusuf R, Frenkel K. 2010. Morphologic transformation of human breast epithelial cells MCF-10A: Dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors. Cancer Cell Int 1: 10-30.